Reimportation Survey Demonstrates Rx Industry’s Public Relations Challenge
Executive Summary
Pharmaceutical companies' opposition to importing drugs from Canada into the U.S. is "unreasonable," according to a survey of Americans released Oct. 9
You may also be interested in...
Nexium DTC Ads Criticized By CMS’ Scully During Medicaid Hearing
Direct-to-consumer advertising for follow-on drugs such as AstraZeneca's Nexium are part of the reason for "huge" Medicaid spending on prescription drugs, Centers for Medicare & Medicaid Services Administrator Thomas Scully told a House Energy & Commerce/Health Subcommittee hearing Oct. 8
Aetna Sees Rx Spending Growing 5%, Premiums At 13%
Aetna sees pharmaceutical spending growing at about one-quarter the peak rate 18 months ago
Medicare Rx “Plan B”: Rep. Burton Chairs First Public Discussion On Fallback
Alternatives to passing a full Medicare prescription drug benefit will be given their first public airing since the Medicare conference committee was formed when the House Government Reform/Human Rights & Wellness Subcommittee convenes for a hearing Sept. 24